Salute e Benessere

Cyclarity Therapeutics Announces Clinical Advisory Board

Cyclarity Therapeutics, Inc. ( https://cyclaritytx.com ), today announced its newly formed Clinical Advisory Board to guide its clinical development of drug candidate UDP-003 for the treatment and prevention of atherosclerosis, primary coronary artery disease, and associated cardiovascular diseases.The Board includes the internationally recognized, preeminent cardiologists: Dr. Prediman K. Shah, Director of Inpatient Cardiology and the Coronary Care Unit at Cedars-Sinai Hospital, Founder...
Nasdaq GlobeNewswire
18/10/2023

The Evolving Market Dynamics of Rare Diseases: WHIM Syndrome, Adrenal Crisis…

DelveInsight has expertise in the rare disease market with an experienced team handling the rare disease domain proficiently. DelveInsight has recently released a series of epidemiology-based market reports on rare diseases including WHIM Syndrome, Adrenal Crisis, MoCoD-A, and Necrotizing Enterocolitis. These reports include a comprehensive understanding of current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032…
PR Newswire
17/10/2023

New Results From HEALEY ALS Platform Trial Show Promise for Treating ALS

"It has been a game changer to have all these new treatments," said Dr. Cudkowicz. "It used to be that when we saw people with ALS, there wasn't a lot we could do to treat the disease. Now, all of a sudden, there is actually a lot we can do that has a direct impact on people's quality of life. There is still a great need for ALS research to better understand the underlying biologies and to develop more targeted treatments. There is a large community of scientists, clinicians…
PR Newswire
17/10/2023

Multi-Billion Opportunities in the Home Elevators Industry, the Market is…

Browse in-depth TOC on "Home Elevator Market" Browse in-depth TOC on "Home Elevator Market" 134 – Tables 114 – Figures 272 – Pages Home Elevators Market Report Scope To Get the Benefit of Our Free Report Customization Service, Send Your Enquiry Here –https://www.arizton.com/customize-report/3972 The home elevator market has a varied structure since each geography has its competitive dynamics and intensity of competition. The APAC can be termed as the most...
PR Newswire
17/10/2023

Neurologist Anthony Lang Presents Groundbreaking News on Parkinson's Disease at…

"We believe this is a radically different way of looking at Parkinson's disease," said Lang. "We've reached a point where, in the era of novel biomarkers … our research needs to be driven by biological determinants of the disease rather than simply limited to a clinical description of the signs and symptoms." "We believe this is a radically different way of looking at Parkinson's disease," said Lang. "We've reached a point where, in the era of novel biomarkers…
PR Newswire
17/10/2023

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad…

Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions said, "Through these enhanced in-vitro biology services, our drug discovery team will be able to provide clients with decision-driving information earlier and will be an even more effective partner in the drug discovery process." Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions said, "Through these enhanced in-vitro biology services, our drug discovery team will be able to provide clients with…
PR Newswire
17/10/2023

Sanofi: Information concerning the total number of voting rights and shares -…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,529,036,828 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
17/10/2023

Groupe Casino: Update on accession to the lock-up agreement relating to the…

Update on accession to the lock-up agreement relating to the financial restructuring of the GroupAppointment of an independent expert Paris, 17 October 2023Further to its previous press releases 1, Casino Group announces that as of 17 October 2023, the last accession date for the lock-up agreement dated 5 October 2023 (the " Lock-up Agreement ") relating to its financial restructuring, the following creditors have acceded to the Lock-up Agreement :creditors economically holding 98...
Nasdaq GlobeNewswire
17/10/2023

Cardiac Biomarkers Market is Set to Reach $26.43 Billion by 2028, Fueled by…

To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3980 To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3980 Cardiac biomarkers play a crucial role in cardiovascular medicine, aiding in the diagnosis, risk stratification, and management of patients with various heart-related conditions. Troponins, CK-MB, BNP, NT-proBNP, myoglobin, CRP, lipid profile, and D-dimer are among the most used cardiac biomarkers,...
PR Newswire
17/10/2023

Population Health Management Market size worth USD 64.12 Billion, Globally, by…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=2071 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=2071 Browse in-depth TOCon" Population Health Management Market " 202 - Pages 126 – Tables 37 – Figures Verified Market Research Report: Population Health Management Market Overview Population Health Management (PHM) is the systematic approach to improving healthcare within a defined population...
PR Newswire
17/10/2023

Ultimovacs Announces NIPU Results Presented at ESMO 2023: Significant and…

UV1, in combination with the checkpoint inhibitors ipilimumab and nivolumab from Bristol-Myers Squibb, demonstrated a clinically meaningful overall survival benefit with no added toxicities, compared to ipilimumab and nivolumab alone, in the second-line treatment of patients with malignant mesothelioma The UV1 cancer vaccination combined with ipilimumab and nivolumab reduced the risk of death by 27%, meeting the protocol predefined threshold for statistical significance, in a...
Nasdaq GlobeNewswire
17/10/2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 41 - 2023

Aggregatedpresentationbydayandbymarket NameofissuerIdentificationcodeof issuer(Legal Entity Identifier)Day of transactionIdentificationcodeof financialinstrumentAggregated daily volume(innumber of shares)Dailyweightedaveragepriceof the purchased shares *Market(MICCode) IPSEN549300M6SGDPB4Z94P1109/10/2023FR00102591503120.50AQEUIPSEN549300M6SGDPB4Z94P1109/10/2023...
Nasdaq GlobeNewswire
17/10/2023

Cleanroom Facility Market Worth $103.72 Billion by 2028, Demand Driven by Rapid…

Browse in-depth TOC on "Cleanroom Facility Market" Browse in-depth TOC on "Cleanroom Facility Market" 243 – Tables 126 – Figures 338 – Pages Cleanroom Facility Market Report Scope · Rapid Development in the Pharmaceutical Sector Enhance Your Business Profits with Customization Options:https://www.arizton.com/customize-report/3965 The cleanroom facility market has industry-specific players committed to developing cleanroom equipment. It is also...
PR Newswire
17/10/2023

SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement

SHL and Lifecore will, pursuant to the terms of its agreement, exchange knowledge and experience in their respective fields, enabling both companies to provide their customers unparalleled guidance in CDMO services and best-in-class options for drug delivery device development. SHL and Lifecore will, pursuant to the terms of its agreement, exchange knowledge and experience in their respective fields, enabling both companies to provide their customers unparalleled guidance in CDMO services and...
PR Newswire
17/10/2023

Invitation to Idorsia's Nine-Month 2023 Financial Reporting webcast and…

Idorsia will publish its Nine-Month Financial Reporting 2023 on Tuesday October 24, 2023, at 07:00 CEST.An investor conference call and webcast will be held to discuss the results on the same day.Date: Tuesday, October 24, 2023 Time: 15:00 CEST / 14:00 BST / 09:00 EDT The call will start with presentations by senior management, followed by a Q&A session.To support your preparations, the consensus estimates can be found under:www.idorsia.com/consensus-estimate...
Nasdaq GlobeNewswire
17/10/2023

Eurobio Scientific: GenDx reduces organ matching time to 3 hours

Eurobio Scientific: GenDx reduces organ matching time to 3 hours Launch of NGS-Turbo, a unique test to match organs on Oxford Nanopore Technologies sequencing devicesA valuable technological partnership with Oxford Nanopore TechnologiesA significant advance in HLA typing Paris, 17 thOctober 2023 – 5:40 pmEurobio Scientific(FR0013240934, ALERS), (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro specialty medical diagnostics and life...
Nasdaq GlobeNewswire
17/10/2023

Healthcare Integration Market size worth USD 5.92 Billion, Globally, by 2030 at…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=4889 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=4889 Browse in-depth TOCon" Healthcare Integration Market " 202 - Pages 126 – Tables 37 – Figures Revolutionizing Healthcare: Global Healthcare Integration Market Poised for Remarkable Growth In a world where collaboration and seamless communication are paramount, the spotlight falls on the...
PR Newswire
17/10/2023

Hemostats Market Worth $3.7 Billion | MarketsandMarkets

The significant growth in the number of hospitals and surgical centers is expected to support the growth of the hemostats market, as these are key end users of hemostats. The number of hospitals and surgical centers is increasing in both developed and emerging countries. The demand for surgical equipment (including medical devices such as hemostats) is high in these newly established surgical centers and hospitals, owing to the increasing patient population base. The significant growth in the...
PR Newswire
17/10/2023

Analytical Standards Market Worth $2.1 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=8484789 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=8484789 Browse in-depth TOC on "Analytical Standards Market"255 - Tables 30 - Figures 252 - Pages Analytical Standards Market Scope: The spectroscopy segment is to register a significant growth rate over the forecast period of 2023-2028. Based on the technique, over the...
PR Newswire
17/10/2023

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Event with Key…

Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Event with Key Opinion Leaders Multiple KOLs highlight varoglutamstat pathology, clinical development and clinical applicability of key endpoints in VIVIAD studyVIVIAD progressing as planned with final results expected Q1/2024 Halle (Saale) / Munich, Germany, October 17, 2023– Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and...
Nasdaq GlobeNewswire
17/10/2023

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

The report said: "The cost of multiple myeloma therapies is high, and the cost of newer therapies such as monoclonal antibodies and CAR T-cell therapy is even higher. This limits the affordability of these therapies for many patients, leading to barriers in access to treatment. The treatment of multiple myeloma is complex and often requires a combination of therapies, including chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. This complexity can lead to…
PR Newswire
17/10/2023

KENNAMETAL LAUNCHES METAL CUTTING ROADSHOW IN NORTH AMERICA

"We're thrilled to bring this experience to our North American customers," said Sanjay Chowbey, President of the Metal Cutting Segment at Kennametal. "We designed a mobile space for manufacturing minds to meet and create, which is something we have great passion for at Kennametal. Our team will be showcasing proven solutions to customers of all sizes and talking to them about how we can help improve productivity and optimize manufacturing performance at their shops."…
PR Newswire
17/10/2023

AIM ImmunoTech Engages Business Development Firm, Azenova, LLC to Catalyze…

AIM ImmunoTech Inc. (NYSE American: AIM)(“AIM”) today announced it has entered into an agreement with Azenova, LLC (“Azenova”), a professional business development (BD) consulting firm, to support efforts to partner AIM's pipeline programs with a particular focus on the company's lead asset, Ampligen®, for the treatment of various malignant solid tumors. Azenova has been engaged to assist AIM with its BD efforts with the goal of entering into a partnership, out-license or other...
Nasdaq GlobeNewswire
17/10/2023

Mark Lovern Joins InSilicoTrials as Chief Platform Officer

"Mark's extensive experience and mastery in model-informed drug development align seamlessly with our vision of revolutionizing the life sciences industry," commented Luca Emili, CEO at InSilicoTrials. "His prior achievements, combined with our groundbreaking AI and simulations platform, will surely take our capabilities to unprecedented heights," he added. "Mark's extensive experience and mastery in model-informed drug development align seamlessly with our vision of…
PR Newswire
17/10/2023
Altri  Comunicati